Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2012-04-20 Remuneration Information
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
2012 0420 DEFA 14A PROXY FAQS
Remuneration Information Classification · 95% confidence The document is titled 'DEFA14A' and references 'Schedule 14A' and 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934.' It contains detailed information about items to be voted on at the Annual Meeting, management's voting recommendations, and explanations related to executive compensation and long-term incentive plans. The content is consistent with materials provided to shareholders to solicit votes for the Annual General Meeting. The presence of detailed proxy voting items and executive compensation discussion aligns with the definition of a Remuneration Information filing, which typically accompanies proxy statements and details compensation for top executives and directors. The document is not a full Annual Report or Earnings Release, nor is it a simple announcement or certification. Therefore, the appropriate classification is 'DEF 14A' (Remuneration Information). The document length (9588 characters) supports it being a substantive filing rather than a brief announcement.
2012-04-20 English
8-K FOR JOHNSON & JOHNSON BY-LAWS AMENDMENTS
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce significant events. The content specifically details amendments to the company's By-Laws, including changes to the roles of Chairman and CEO. It does not contain financial statements or detailed financial data, nor is it an annual or quarterly report. The document is focused on governance changes, specifically amendments to corporate by-laws, which falls under Board/Management Information. The document length is short (2562 characters), and it is not an announcement of a report publication but the actual filing of the amendment event. Therefore, the appropriate classification is MANG (Board/Management Information).
2012-04-19 English
M&A Activity 2012
M&A Activity Classification · 95% confidence The document is a Form 8-K, which is a current report filed with the SEC to announce major events that shareholders should know about. The content describes an extension of the Outside Date in a merger agreement between Johnson & Johnson and Synthes, Inc. This is an update related to merger activity but does not constitute the merger filing itself (like a DEFM14A or SC TO-*). The document is short (2236 characters) and is a regulatory announcement of an event related to a merger. According to the filing definitions, announcements related to merger proposals or takeover bids fall under M&A Activity (TAR). Therefore, this document is best classified as M&A Activity (TAR).
2012-04-19 English
Earnings Release 2012
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and includes a press release announcing sales and earnings for the first quarter ended April 1, 2012. It also references unaudited supplementary sales data and condensed consolidated statement of earnings for the first quarter. This indicates it is an initial announcement of quarterly financial results, which aligns with the definition of an Earnings Release (ER). The document length is short (2374 characters) and contains the actual earnings announcement, not just a notice or link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is Earnings Release (ER).
2012-04-17 English
2012 0409 MCCOY RESIGNATION FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filing with the SEC, dated April 9, 2012, reporting the resignation of a Vice Chairman of the Executive Committee. The key section is Item 5.02, which covers departure of directors or certain officers. There is no financial data or report content, only an announcement of a management change. This fits the category of Board/Management Information (MANG). The document length is short and it is a current report on a specific event, not a full financial report or earnings release.
2012-04-09 English
2012 MOXY VOTE
Remuneration Information Classification · 100% confidence The document is titled 'SCHEDULE 14A' and is identified as a 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934.' It includes detailed information about the annual meeting of shareholders, director nominees, corporate governance, executive compensation, and other items to be voted on. The presence of terms like 'Definitive Proxy Statement,' 'Proxy Solicitation Filings (DEF 14A),' and detailed executive compensation data confirms this is a proxy statement filing. The document is not a full annual report, earnings release, or other financial report but rather a solicitation of shareholder votes and related information. Therefore, the correct classification is 'DEF 14A' which corresponds to Remuneration Information and proxy statements detailing executive compensation and voting materials.
2012-04-03 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.